These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Personalising the treatment of prostate cancer. Gunjur A Lancet Oncol; 2015 Dec; 16(16):e592. PubMed ID: 26549591 [No Abstract] [Full Text] [Related]
3. Therapeutic Value of an Integrin Antagonist in Prostate Cancer. Philippe CL Curr Drug Targets; 2016; 17(3):321-7. PubMed ID: 26648077 [TBL] [Abstract][Full Text] [Related]
4. Growth factor and signaling pathways and their relevance to prostate cancer therapeutics. Wozney JL; Antonarakis ES Cancer Metastasis Rev; 2014 Sep; 33(2-3):581-94. PubMed ID: 24402967 [TBL] [Abstract][Full Text] [Related]
5. Targeted therapy in the treatment of castration-resistant prostate cancer. Derleth CL; Yu EY Oncology (Williston Park); 2013 Jul; 27(7):620-8. PubMed ID: 23977754 [TBL] [Abstract][Full Text] [Related]
6. Prostate cancer proteomics. Masters JR OMICS; 2011 Mar; 15(3):169-71. PubMed ID: 21319990 [TBL] [Abstract][Full Text] [Related]